Immunotherapy developer Immune Design said it will halt a Phase III trial for its lead pipeline candidate, the cancer vaccine CMB305, following disappointing Phase II results in synovial sarcoma, and ...
Sightline, the Johns Hopkins program that will transition the university and health system from SAP to Workday in 2027, has entered its design and build phase. This kicks off a year of activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results